Current portfolio
XyloCor Therapeutics
US biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease
- SektorHealthcare
- LandUnited States
- FondLSP 6
- Entry2018
- Web

- SektorHealthcare
- LandUnited States
- FondLSP 6
- Entry2018
- Web
